Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology.
Nexo Therapeutics offers treatments for some of cancer's most intractable targets.
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.
Light Horse Therapeutics is a small molecule drug discovery, pioneering to target that causes disabling and life-threatening diseases.
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
Belharra Therapeutics disrupts the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform.
Antag Therapeutics provides therapeutic peptides for the treatment of dietary-related metabolic diseases.
Launchpad Therapeutics operates as an antibody-focused precision oncology company.
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.
Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
Dayra Therapeutics manufactures peptide based medicines.
Halio is developing adaptive, dynamic glass for the commercial, residential, and automotive markets.
Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.
Gate Bioscience is a biotechnology company that specializes in a small molecule modality to treat biology’s intractable diseases.
Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations.
Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.
Anokion is harnessing the power of natural immune equilibrium to develop solutions for antigen-specific immune tolerance.
Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders
AllRock Bio is a drug developing firm that offers novel therapies to patients suffering hypertension and other fibrotic conditions.
Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.
Borealis Biosciences is a company in the field of next-generation RNA medicines.
858 Therapeutics develops small molecule drugs targeting oncology and immunology.
Versant Ventures has invested in 89 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Versant Ventures's top investment sectors include Biotechnology, Therapeutics, Health Care, Life Science, Medical. The firm invests across 24 different industry categories.
Among tracked funding rounds, Monte Rosa Therapeutics received $300.0M in a Post-IPO Equity round. Versant Ventures's total known invested capital is $4.4B.
Versant Ventures's average investment size is $68.2M across its portfolio of 89 companies.
Recent Versant Ventures portfolio additions include Tentarix Biotherapeutics, Nexo Therapeutics, Abdera Therapeutics, Light Horse Therapeutics, Monte Rosa Therapeutics. These companies were founded in 2020 or later.